Tafasitamab 12714-0212
Product NDC
12714-0212- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Solution
- Product Type
- Bulk Ingredient
- Marketing Start
- July 31, 2020
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tafasitamab | 40 mg/40mg |
Packaging Options(1)
40 mg in 1 TANK (12714-212-40)